The majority of IgM secreting DLBCL described in a case series by Cox et al. [42] were of the activated B-cell subtype which are known to have an adverse prognosis compared to the germinal centre B-cell subtype of DLBC [42,44]. This evidence concerns the gene CD40LG and diffuse large B-cell lymphoma.